
Illumina, Inc.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Latest Content

Streamline Somatic Variant Interpretation

Illumina Connected Insights

Break Through the NGS Interpretation Bottleneck To Improve Patient Outcomes

Simultaneous Profiling of the Epigenome and Transcriptome at a Single-Cell Level

New State-of-the-Art Genomic Services Facility Opening in the UK

Veracyte Announces In Vitro Diagnostic Agreement With Illumina

Partnerships Provide Automated Library Preparation Solutions

Eremid® Genomic Services Expands Long-Read HiFi Sequencing Capabilities With PacBio Revio

Pixelgen Technologies Launches First Molecular Pixelation Kit for 3D Spatial Analysis of Cell Surface Proteins
